Coprococcus is a genus of anaerobic cocci which are part of the human faecal microbiota.[1] Despite the depletion of Coprococcus was found in colon cancer, there is no evidence for its protective role against colon cancer .[2]
| Coprococcus | |
|---|---|
| |
| Scientific classification | |
| Domain: | |
| Phylum: | |
| Class: | |
| Order: | |
| Family: | |
| Genus: | Coprococcus Holdeman and Moore 1974
|
| Species | |
|
See text | |
Three species have been described:[3]
- Coprococcus catus Holdeman and Moore 1974
- Coprococcus comes Holdeman and Moore 1974
- Coprococcus eutactus Holdeman and Moore 1974
C. comes may seem to play a role in cases of resistance against blood pressure medicine.[4]
Etymology
edit'kopros' - excrement, faeces; 'kokkos' - berry; 'Coprococcus' - faecal coccus
References
edit- ^ Holdeman, L. V.; Moore, W. E. C. (1974). "New Genus, Coprococcus, Twelve New Species, and Emended Descriptions of Four Previously Described Species of Bacteria from Human Feces". International Journal of Systematic Bacteriology. 24 (2): 260–277. doi:10.1099/00207713-24-2-260.
- ^ Xia, Li C.; Liu, Gang; Gao, Yingxin; Li, Xiaoxin; Pan, Hongfei; Ai, Dongmei (2019). "Identifying Gut Microbiota Associated With Colorectal Cancer Using a Zero-Inflated Lognormal Model". Frontiers in Microbiology. 10: 826. doi:10.3389/fmicb.2019.00826. ISSN 1664-302X. PMC 6491826. PMID 31068913.
- ^ "Coprococcus".
- ^ Yang et al (2022). Identification of a gut commensal that compromises the blood pressure-lowering effect of ester angiotensin-converting enzyme inhibitors. https://doi.org/10.1161/HYPERTENSIONAHA.121.18711. Hypertension. 2022;79:1591–1601